A digital service from FCT Overcoming cisplatin resistance in non-small cell lung cancer with Mad2 silencing siRNA delivered systemically using EGFR-targeted chitosan nanoparticles.
Chicago Style (17th ed.) CitationOvercoming Cisplatin Resistance in Non-small Cell Lung Cancer with Mad2 Silencing SiRNA Delivered Systemically Using EGFR-targeted Chitosan Nanoparticles.
MLA (9th ed.) CitationOvercoming Cisplatin Resistance in Non-small Cell Lung Cancer with Mad2 Silencing SiRNA Delivered Systemically Using EGFR-targeted Chitosan Nanoparticles.
Warning: These citations may not always be 100% accurate.